SCHEMBL10194193

SCHEMBL10194193

CC1(C)OC[C@@H](CCc2ccc(-c3c(C#N)c(N)nc(S)c3C#N)cc2)O1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 14/20 0.38
▸ HSD17B10 Q99714 8/20 0.38
▸ MEN1 O00255 4/20 0.38
▸ KMT2A Q03164 4/20 0.38
▸ HTT P42858 3/20 0.38
▸ MAPT P10636 3/20 0.38
▸ MAPK1 P28482 3/20 0.38
▸ ALOX15 P16050 2/20 0.38
▸ LMNA P02545 1/20 0.38
▸ HPGD P15428 9/20 0.38
▸ ALDH1A1 P00352 7/20 0.38
▸ NPSR1 Q6W5P4 5/20 0.36
▸ RXFP1 Q9HBX9 3/20 0.36
▸ PPARG P37231 1/20 0.36
▸ NCOA2 Q15596 1/20 0.36
▸ NCOA1 Q15788 1/20 0.36
▸ NCOA3 Q9Y6Q9 1/20 0.36
▸ USP2 O75604 1/20 0.36
▸ TSHR P16473 1/20 0.36
▸ ADORA1 P30542 2/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12163726 1.00 KDM4E (0.38) KDM4EHSD17B10MEN1KMT2AHTT
SCHEMBL16358105 0.94 KDM4E (0.36) KDM4EHSD17B10MEN1KMT2AHTT
SCHEMBL381709 0.84 ADORA2B (0.43) KDM4EHSD17B10MEN1KMT2AMAPT
SCHEMBL252404 0.84 ADORA2B (0.43) KDM4EHSD17B10MEN1KMT2AMAPT
SCHEMBL3602017 0.84 ADORA2B (0.43) KDM4EHSD17B10MEN1KMT2AMAPT
SCHEMBL12163724 0.84 MAPT (0.46) KDM4EHSD17B10MEN1KMT2AHTT
SCHEMBL3304369 0.80 KDM4E (0.34) KDM4EHSD17B10MEN1KMT2AHTT
SCHEMBL13285361 0.78 ADORA1 (0.48) KDM4EHSD17B10MEN1KMT2AHTT
SCHEMBL10194182 0.78 ADORA1 (0.48) KDM4EHSD17B10MEN1KMT2AHTT
SCHEMBL12163870 0.77 ADORA1 (0.45) KDM4EHSD17B10MEN1KMT2AHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2235011-B1 SUBSTITUTED PYRROLO[2, 3-B]AND PYRAZOLO[3, 4-B]PYRIDINES FOR USE AS ADENOSINE RECEPTOR LIGANDS Bayer Pharma AG (DE) 2012-01-25 — — EP disclosed
WO-2009015776-A1 SUBSTITUTED ARYLOXAZOLES AND THE USE THEREOF BAYER SCHERING PHARMA AKTIENGESELLSCHAFT (DE) 2009-02-05 — — WO disclosed
Send feedback